ENTITY

Sichuan Biokin Pharmaceutical (688506 CH)

22
Analysis
Health CareChina
Sichuan Biokin Pharmaceutical Co.,Ltd. operates as a pharmaceutical company. The Company produces children's medicine, cardiovascular drugs, anesthetics, chronic disease drugs, and more. Sichuan Biokin Pharmaceutical conducts businesses worldwide.
more
Refresh
07 Dec 2023 07:12

China: Consolidated Flows at the Close Tomorrow

Local indices in China rebalance tomorrow and we estimate passives will need to trade around CNY 54bn (US$7.5bn). There will be big impact on some...

Logo
442 Views
Share
03 Dec 2023 05:40

Index Rebalance & ETF Flow Recap: KWEB, CSI300/500, STAR50, SSE50, ChiNext, SET50, Chips, Denso, SPX

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
537 Views
Share
bearishNinebot
13 Nov 2023 07:32

STAR50 Index Rebalance Preview: Big Impact Expected on the Changes

There could be 1 index change in Dec. The ETF inflows over the last few months results in passives needing to trade 9-25x ADV on the add/delete....

Logo
524 Views
Share
bearishNinebot
25 Oct 2023 12:48

Quiddity Leaderboard STAR 50 Dec 23: One ADD and One DEL; Ninebot Could Underperform AIMA

Final Expectations for the Dec 23 STAR 50 Rebalance: Sichuan Biokin Pharmaceutical (688506 CH) is an expected ADD and Ninebot (689009 CH) is an...

Share
17 Sep 2023 06:18

Index Rebalance & ETF Flow Recap: HSCEI, HSTECH, CSI500, STAR50, FnGuide Top10

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
748 Views
Share
x